News for Creightons Plc (CRL.L)

  • Published at
    by prnewswire.com
    mixed
  • Published at
    by businessweekly.co.uk
    mixed

    Region’s M & A haul tops $100 billion in 12 months

    Acquisitions involving East of England companies in the past 12 calendar months have raced past $100 billion thanks to a blockbusting start to M & A activity in 2021.  While the DeepTech and life sciences sectors have dominated, the Covid-clouded business environment has acted as a catalyst for a high number of B2B Mergers & Acquisitions. "Business news from Cambridge and the
  • Published at
    by businessweekly.co.uk
    positive

    Creightons adds gloss and makes eyes at beauty firm

    Creightons plc in Peterborough is weighing up its options over a potential second bid for InnovaDerma, a global maker of Skinny Tan and other health and beauty products.  The company has had one bid rejected but market watchers reckon this was just an opening gambit and that a deal, believed to be worth around £7.6 million, will prove tempting to InnovaDerma shareholders now
  • Published at
    by yahoo.com
    mixed

    Form 8.3 - [Creightons plc] - Opening Disclosure - (CGWL)

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCREIGHTONS PLC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure02 FEBRUARY 2021(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO We control no voting rights in the Offeree – INNOVADERMA PLC 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: ORDINARY 1p InterestsShort positionsNumber%Number%(1) Relevant securities owned and/or controlled:1,039,0001.6047 (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL:1,039,0001.6047 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant securityPurchase/sale Number of securitiesPrice per unitNone (b) Cash-settled derivative transactions Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unitNONE (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unitNONE (ii) Exercise Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)NONE 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached?NO Date of disclosure:03 FEBRUARY 2021Contact name:MARK ELLIOTTTelephone number:01253 376539 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.